Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Impel Neuropharma Announces First Patient Dosed In INP104 Trial

americanpharmaceuticalreviewAugust 27, 2018

Tag: Impel Neuropharma Announces , INP104 , trial

PharmaSources Customer Service